Amgen Boosts Bid for Onyx to $130 a Share

Aug. 7 (Bloomberg) -- Amgen, the drugmaker in pursuit of Onyx Pharmaceuticals, boosted its offer for the company to $130 a share, according to a person familiar with the matter. Cristina Alesci reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Saudi Arabia Said to Probe Bank Currency Trades
14:56 - Banks in Saudi Arabia are coming under fresh pressure over products that allow speculators to bet against the kingdom’s currency peg, according to people with knowledge of the matter. Western Asset Management Company Portfolio Manager John Bellows weighs in on "Bloomberg ‹GO›." (Source: Bloomberg)
  • Bill Gross on Fed Rates, Janus Objectives, Fund Fees
  • Chicago Embraces Entrepreneurship
  • Lenovo CFO on Slowing PC Sales, Q4 Earnings